Korean J Pediatr.  2014 Oct;57(10):440-444. 10.3345/kjp.2014.57.10.440.

Serum interleukin-1beta and tumor necrosis factor-alpha in febrile seizures: is there a link?

Affiliations
  • 1Department of Pediatrics, Qazvin Children Hospital, Qazvin University of Medical Sciences, Qazvin, Iran. Abolfazl473@yahoo.com

Abstract

PURPOSE
Febrile seizures are induced by fever and are the most common type of seizures in children. Although numerous studies have been performed on febrile seizures, their pathophysiology remains unclear. Recent studies have shown that cytokines may play a role in the pathogenesis of febrile seizures. The present study was conducted to identify potential links between serum interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and febrile seizures.
METHODS
Ninety-two patients with simple or complex febrile seizures (46 patients per seizure type), and 46 controls with comparable age, sex, and severity of temperature were enrolled.
RESULTS
The median concentrations of serum IL-1beta in the simple, complex febrile seizure, and control groups were 0.05, 0.1, and 0.67 pg/mL, respectively (P=0.001). Moreover, the median concentrations of TNF-alpha in the simple, complex febrile seizure, and control groups were 2.5, 1, and 61.5 pg/mL, respectively (P=0.001). Furthermore, there were significant differences between the case groups in serum IL-1beta and TNF-alpha levels (P<0.05).
CONCLUSION
Unlike previous studies, our study does not support the hypothesis that increased IL-1beta and TNF-alpha production is involved in the pathogenesis of febrile seizures.

Keyword

Interleukin-1beta; Tumor necrosis factor-alpha; Febrile seizures

MeSH Terms

Child
Cytokines
Fever
Humans
Interleukin-1beta*
Seizures
Seizures, Febrile*
Tumor Necrosis Factor-alpha*
Cytokines
Interleukin-1beta
Tumor Necrosis Factor-alpha
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr